-
Odonate Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2018
firstwordpharma
February 24, 2019
Odonate Therapeutics, Inc.(NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and extend the lives of patients with cancer, today announced financial results for the three and twelve months ended
-
Insmed Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business Update
firstwordpharma
February 24, 2019
Insmed Incorporated a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today reported financial results for the fourth quarter and full year ended December 31, 2018 and provided a business u
-
Momenta Pharmaceuticals Reports Fourth Quarter and Full Year 2018 Financial Results
firstwordpharma
February 24, 2019
Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology company focused on discovering and developing novel biologic therapeutics to treat rare immune-mediated diseases, today reported its financial results for the fourth quarter and full year ended
-
Suven Life Sciences announces financial results for quarter ending June 30, 2018
financialexpress
August 17, 2018
Suven’s income at INR 1998 mn; PAT at INR 388 Mn for the quarter ended June 2018
-
Sun Pharma reports Q1FY19 results
financialexpress
August 17, 2018
Sun Pharmaceutical Industries reported financials for the first quarter ending June 30, 2018.
-
Indoco declares Q1FY19 results
financialexpress
August 16, 2018
Indoco Remedies posted revenues of INR 212.5 crores during the first quarter of FY 2018-19, as against INR 204.2 crores, for the same quarter last...
-
Evolva Provides 2017 Financial Results and Business Highlights
biospace
March 21, 2018
Evolva (SIX:EVE) posted its financial resultstoday for the period from 1 January to 31 December 2017
-
Arena Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2017 Financ
biospace
March 15, 2018
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), today provided a corporate update and reported financial results for the fourth quarter and full-year ended December 31, 2017.
-
Eiger BioPharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results
biospace
March 13, 2018
Eiger BioPharmaceuticals, Inc.today financial results for the three months and year ended December 31, 2017 and provided a business update.
-
ArQule Reports Fourth Quarter and Full Year 2017 Financial Results
biospace
March 06, 2018
ArQule, Inc. (NASDAQ: ARQL) today announced its financial results for the fourth quarter and full year of 2017.